Drug intelligence / Profile preview

titrated oral misoprostol solution

Development stage
Approved
Lead developer
China Medical University Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Titrated oral misoprostol solution is a liquid formulation of the synthetic prostaglandin E1 (PGE1) analog, misoprostol, being evaluated by China Medical University Hospital for labor augmentation. Misoprostol acts as an agonist at prostaglandin E receptors (primarily the EP3 subtype) in the uterine myometrium, which triggers intracellular calcium release and leads to potent uterine contractions. While traditionally administered as a tablet for gastric ulcer prevention or off-label for labor induction, this specific titrated oral solution allows for precise dose adjustments to achieve adequate uterine activity while minimizing the risk of uterine tachysystole. A Phase 4 randomized controlled trial (NCT02433106) compares this titrated oral regimen to the standard of care, intravenous oxytocin, in pregnant women experiencing inadequate uterine contractions during labor.

Brand names
Cytotec
Other names
oral misoprostol solutionmisoprostol solution
02

Targets

PTGER2 (Prostaglandin E2 receptor EP2)PTGER1 (Prostaglandin E Receptor 1)PTGER4 (Prostaglandin E2 receptor EP4 subtype)PTGER3 (Prostaglandin E2 receptor EP3 subtype)

Beyond the preview

Go deeper on titrated oral misoprostol solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on titrated oral misoprostol solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call